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Abstract: Congenital ptosis is a rare condition characterized by lower positioning of the 
upper eyelid that is present at birth and is a clinical condition that is persistent if not treated. 
It may be unilateral or bilateral and may be associated with other ocular disorders or systemic 
conditions, including Marcus Gunn, Horner, and Duane syndromes. It is a benign condition but 
causes functional, cosmetic, and psychological problems in children. However, not all patients 
need to undergo surgery, and usually only patients at risk of amblyopia need a prompt surgi-
cal correction, while in other cases, surgery can be postponed. The grade of ptosis, the eyelid 
function, and the amblyopic risk are the parameters that affect the ophthalmologist’s decision 
on timing of surgery and the surgical technique to be used. In fact, there are several types of 
surgical techniques to correct a congenital ptosis, although very often more than one is needed 
to obtain an acceptable result. This paper reviews the causes of congenital ptosis and associated 
diseases. Particular emphasis is given to surgical management and different procedures available 
to correct the upper eyelid anomaly and avoid permanent damage to visual function.
Keywords: ptosis, extraocular muscle development, neurologic dysfunction, surgical approach
Introduction
Congenital ptosis is a rare condition characterized by an abnormal drooping of the 
upper eyelid that is present since birth or occurs within the first year of life, resulting 
in the reduction of the vertical palpebral fissure. Although isolated congenital ptosis 
can have an autosomal, either dominant or recessive, inheritance, it may be part of a 
larger spectrum of birth defects combined with other ocular or systemic conditions. 
It usually presents with a variable loosening of the upper eyelids due to a loss of 
muscular or nerve function that can be unilateral or bilateral.1–3
The superior branch of the third cranial nerve (CN III) is involved in the con-
traction of the levator palpebrae superioris muscle and the superior rectus muscle 
that are responsible for the elevation of the eyelids. The impairment of this func-
tion leads to abnormal visual development, resulting in a long-lasting uncorrected 
astigmatism or deprivational amblyopia. This form of amblyopia is defined as a 
disruption in the normal image-forming ability of the eye early in life caused by 
diminished performance of the visual system and severe reduction of the visual 
acuity due to an obscured visual field.4 The incidence of amblyopia in the over-
all population has been assessed at ~3%. However, a recent paper published by 
Willshaw5 provides information of an overall rate of amblyopia of up to 26.45% 
in a group of pediatric patients with blepharoptosis of different etiologies. Among 
them, 18.7% have visually significant refractive errors, while 14.19% are present 
with squint.
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Patients with congenital ptosis have to be closely moni-
tored in order to preserve their visual function and establish 
timely and appropriate medical or surgical treatment if 
needed.6
This review focuses on the genetics, main causes, and 
management of congenital ptosis, with a particular focus 
on the timing of surgical intervention and the options that 
are available.
Prevalence and incidence
The incidence rate of congenital ptosis worldwide has not 
been officially reported. However, according to a recent study 
over a 40-year time period on the incidence and demographics 
of childhood ptosis published by Griepentrog et al,7 ~90% of 
known cases were of congenital onset, one out of 842 births. 
Only 3% were bilateral and the left side was consistently 
more affected (68%) compared to the right.
These data have been recently confirmed by a retrospec-
tive study conducted on 336 children with ptosis where 69% 
were congenital. Left ptosis was again clearly predominant 
(74%) and unilateral in 65% of cases.8
Berry-Brincat and Willshaw5 reviewed all cases of 
childhood ptosis over a 9-year time period at the Birming-
ham Children’s Hospital. They estimated the incidence of 
congenital ptosis at 41% (76 children out of 186) while in 
the remaining patients, ptosis was an associated sign of a 
systemic syndrome.
These results apparently contradict the report of one of the 
largest studies conducted on .700,000 people from multiple 
Chinese provinces by Hu in 1987.9 In fact, the prevalence 
of congenital ptosis in that study was 0.18%, with a pre-
dominance of sporadic onset. Although these findings are not 
suitable to extrapolate to other ethnic groups, it is important 
to note that there was an autosomal recessive pattern of 
inheritance in 14.5% of patients and an autosomal dominant 
pattern in 18.4% of patients of the same group.
Genetics
Many theories have been proposed regarding the pathogenesis 
of congenital ptosis. Among them, only a few authors under-
lined the high prevalence of chromosomal alterations detected 
by genomic hybridization or karyotyping such as chromo-
somal deletion, chromosomal pericentric inversion, chromo-
somal micro-replication, or mosaic gain. The history of ptosis 
associated with developmental delay or a systemic disorder, 
should prompt an early genetic consultation and chromosomal 
testing in order to plan timely treatment and avoid visual loss. 
A recent study conducted by Stein et al10 demonstrated the 
relationship between congenital ptosis and the underlying 
chromosomal alterations, genetic syndromes, or neurologi-
cal disorders. The first genetic locus identified for isolated 
congenital ptosis was (PTOS1) in the short arm of human 
chromosome 1 (1p32–34.1). According to Engle11 the criti-
cal region for the PTOS1 disease gene is 3 cM, an autosomal 
dominant inherited gene with incomplete penetrance pattern, 
defined by the polymorphic markers D1S447/D1S2733 and 
D1S1616. A few reports by McMullan et al12 suggested a 
clearly distinct pattern of inheritance and defined a new con-
dition of X-linked dominant inheritance in a family affected 
by isolated, congenital bilateral ptosis where no male-to-male 
transmission was observed. More accurate and advanced 
molecular and genetic analysis led to definition of a critical 
region between Xq24 and Xq27.1. Further studies conducted 
by the same group of McMullan et al13 identified two chro-
mosome breakpoints and a de novo balanced translocation of 
chromosomes 10 and 8 affecting the ZFH4 gene (8q21.1). The 
modified gene, which codes for a zinc-finger home domain 
protein and acts as a transcription factor, leads to an impaired 
development of cranial nerve tissue and muscles. Depending 
on the condition that exacerbates the ptosis, a variety of genes 
with new loci involved in this process can be identified. A 
group of systemic syndromes that commonly present with 
congenital ptosis because of abnormal extraocular muscle 
innervation are reviewed.
1. Isolated Duane syndrome. This disorder recognizes 
cytogenetic abnormalities both on the q arm of chromo-
some 2 (2q31) and the q arm of chromosome 8. In this 
condition, the lateral rectus muscle acquires an aberrant 
innervation from the CN III as a result of a deficient 
function of the sixth cranial nerve. Both abduction and 
adduction may be affected as it presents with one of the 
three types of diseases known.14–18
2. Autosomal-dominant blepharophimosis-ptosis-epicanthus 
inversus syndrome (BPES). An Italian study published in 
Nature19 identified a winged helix/forkhead transcription 
factor gene, FOXL2, which is mutated in BPES. This 
mutation produces altered proteins, which are truncated 
in type I BPES and larger in type II BPES. The modified 
proteins are expressed both in the mesenchyme of devel-
oping eyelids and the ovary. A heterozygous mutation in 
the UBE3B gene (12q23) is the underlying cause of the 
blepharophimosis-ptosis-intellectual disability syndrome, 
which is responsible for the intellectual infirmity in 
patients with BPES.
3. Lymphedema-distichiasis-syndrome. Although it is not 
specifically one of the main causes of congenital ptosis, 
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it is caused by a mutation of the FOX2 gene, a member of 
the same forkhead/winged-helix gene family responsible 
for BPES. It is an autosomal dominant condition typically 
characterized by distichiasis of the upper and lower lids 
and lymphedema of the extremities, with ptosis present 
in 30% of cases.20,21
4. Congenital fibrosis of the extraocular muscles (CFEOM) 
types 1, 2, and 3 are autosomal dominant (types 1 and 3) 
and recessive (type 2) disorders belonging to the congeni-
tal cranial dysinnervation disorder family. CFEOM1 is an 
autosomal dominant condition that results from heterozy-
gous mutations in KIF21A (12q12). Genetic analysis 
conducted on a group of people affected by CFEOM3 
reveals linkage to markers on 16q24.2q24 inherited in an 
autosomal dominant pattern with incomplete penetrance 
throughout the family.22,23
5. Congenital myasthenic syndrome is a heterogeneous 
group of autosomal recessive disorders characterized 
by altered neuromuscular transmission. Mild ptosis 
is the most common sign at first inspection and usu-
ally does not require surgical intervention. Congenital 
myasthenic syndrome may be associated to other ocular 
or bulbar signs or to a decreased pulmonary function. 
The majority of all cases of congenital myasthenic syn-
drome are characterized by an altered neuromuscular 
transmission, mainly affecting the postsynaptic region, 
due to genetic mutations of the proteins involved in this 
signaling. Gene defects may otherwise affect presynaptic 
and synaptic structures. Recent discoveries focus on the 
muscle-specific protein kinase (MUSK, 9q31.3–q32) 
gene and the RAPSN gene (11p11.2–p11.1), which play 
crucial roles, respectively, in synaptic differentiation and 
clustering of acetylcholine receptors.24
Causes
Congenital ptosis can be associated with both anomalies of 
extraocular muscle development and of innervation.
Muscle
Histologically, the levator muscle and the aponeurotic tissues 
of patients with congenital ptosis are replaced by fibrous and 
adipose tissue to a grade of severity, which causes, in worse 
cases, a complete replacement of the striated muscle.25
Congenital fibrosis of the extraocular muscles
CFEOM types 1, 2, and 3 are a group of conditions that 
share common features such as paralytic strabismus or other 
restricted eye movements, ophthalmoplegia and ptosis.22,23,26–29 
CFEOM1 is an autosomal dominant disorder with severe 
restriction of elevation of the eye above the midline and a 
typical chin-up position of the head. Heterozygous mutations 
in KIF21A (12q12), a kinase protein involved in the process 
of neuronal development and axonal signal conduction, have 
been individuated. Inappropriate division of the oculomotor 
cranial nerve due to the lack of such signals causes severe 
atrophy and impaired function of the levator palpebrae 
superioris and superior rectus muscle. CFEOM2 is an auto-
somal recessive disease due to mutations in PHOX2A/ARIX 
(11q13) characterized by congenital bilateral ptosis with 
exotropic ophthalmoplegia. It may be associated with pupil-
lary defects, in particular, miosis. Guo et al30 suggested that 
mutation in PHOX2A/ARIX transcription factor leads to 
congenital ptosis in CFEOM2 as a result of hypoplasia of the 
oculomotor and trochlear cranial nerve nuclei derived from 
incomplete development. CFEOM3 is an autosomal dominant 
condition with an incomplete penetrance pattern character-
ized by a mutation either to chromosome 16q24.2–q24.3 or 
in KIF21A. Although patients present with a heterogeneous 
phenotype, they all manifest with ptosis and ophthalmople-
gia. Cognitive impairment, facial dysmorphisms, and/
or digital anomalies, are also common features. Doherty 
et al31 proposed to consider CFEOM3 as a variant form of 
CFEOM that differed from the first type both genotypically 
and phenotypically.
Currently, the term congenital cranial dysinnervation 
disorder32 is preferred to define these syndromes. This 
updated definition, in fact, reflects the underlying cause of 
cranial nerve/brainstem deficient development and aberrant 
innervation of the extraocular musculature.
This group of disorders may also include Duane’s syn-
drome and Marcus Gunn jaw winking syndrome.
Nerves
Congenital ptosis can also be the result of a neurologic dys-
function or a neuromuscular junction failure of the levator 
muscle.33 The superior branch of the CN III innervates the 
levator palpebra superioris muscle and the superior rectus 
muscle. CN III is located in the midbrain and is composed 
of multiple subnuclei. The oculomotor nucleus, ventrally 
located, controls the levator muscle and the extraocular 
muscles, with the exception of the lateral rectus and the supe-
rior oblique. The inferior oblique subnucleus located above, 
serves the ipsilateral muscle. The sphincter pupillae muscle 
and the ciliary muscle are otherwise controlled by parasympa-
thetic fibers originating from the Edinger–Westphal nucleus 
through the ciliary ganglion.
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Duane retraction syndrome
Duane retraction syndrome is a congenital eye movement 
pathological condition that belongs to the family of incomi-
tant strabismus, characterized by an incomplete development 
of the abducens nerve and corresponding midbrain nucleus. 
As a result, the lateral rectus is not properly innervated by 
the sixth cranial nerve and acquires an aberrant innerva-
tion by a branch of the CN III. The most common features 
include contraction of the palpebral fissure and reduction or 
total absence of either adduction or abduction.15 Although 
the synkinesis produced does not involve lid innervation, 
retraction of the globe and ptosis may result on attempted 
adduction.34
If not diagnosed early in children, Duane retraction syn-
drome can lead to amblyopia, a permanent uncorrectable 
loss of vision.
Duane syndrome is often clinically subdivided into three 
types 1–3 with a broad spectrum of severity and phenotypic 
segregation as described by Chung et al35 within the same 
family. Type 1 is a marked limitation of abduction combined 
with contraction of the lateral and the medial rectus muscles 
when adduction is struggled. Adduction is not altered in this 
case. Type 2 is a limitation of adduction in the affected eye 
while abduction is usually preserved. Huber (1974) explains 
this condition as a result of the concomitant action of both 
lateral and medial rectus muscles while attempting an adduc-
tion.36 Type 3 refers to a marked limitation of both adduction 
and abduction. Chung et al, Evans et al, and Al-Baradie et al 
described the concomitant presence of more than one type 
of Duane syndrome within a single pedigree.16,36,37 Duane 
syndrome occurs in .65% of cases as an isolated finding 
that can be associated with further ocular, neural, skeletal 
or auricular, malformations, as well as with other well-
defined syndromes such as morning glory syndrome and 
Goldenhar syndrome.
Marcus Gunn syndrome
One of the more common congenital oculofacial synkineses, 
the Marcus Gunn syndrome, accounts for almost 5% of all 
congenital ptosis. Described by Gunn in 1883, the synkinetic 
winking motion of the eyelid on the movement of the jaw 
bears his name. Typically, the infant affected presents with 
variable degree of severity of blepharoptosis that may be 
either bilateral or, more frequently, unilateral. The wink 
reflex is characterized by a momentary upper eyelid retrac-
tion upon stimulation of the ipsilateral pterygoid muscle, 
elicited by chewing, laughing, or by usual movements of the 
jaw. The underlying cause of this reflex may be referred to 
an anomalous link between the motor fibers that innervate 
the levator superioris muscle, which belongs to the oculo-
motor nerve, and those belonging to the motor branches of 
the trigeminal nerve that innervate the external pterygoid 
muscle. The synkinetic winking motion rapidly ends with a 
quick return to a lower position.38–40
BPeS
BPES is a rare disorder with an autosomal dominant pat-
tern of inheritance characterized by blepharophimosis, 
blepharoptosis, epicanthus inversus, and telecanthus. The 
main findings are the horizontal narrowing of the eyelids 
(blepharophimosis), the loosening of the upper eyelids 
(blepharoptosis) followed by a skinfold that goes vertically 
from the lower eyelid to one side of the nose (epicanthus 
inversus). Because of these anatomical malpositions, it is 
usually associated with lacrimal duct anomalies. Additional 
signs include a broad nasal bridge, short philtrum, or low 
set ears. Zlotogora et al41 identified two types of BPES. 
In type 1 BPES, palpebral anomalies are associated with 
premature ovarian failure, early menopause, or complete 
infertility inherited as an autosomal dominant sex-limited 
trait. Type 2 presents with the same facial features without 
premature ovarian failure. Diagnosis of BPES is based on 
presence at birth of the four major eyelids features and when 
identified later in life, is often associated with premature 
ovarian failure (amenorrhea of .6 months, age ,40 years, 
and follicle stimulating hormone concentration .40 IU/L); 
this is type 1 BPES. The clinical suspicion is confirmed by 
the identification of a genetic mutation in the FOXL2 gene 
(3q23). FOXL2 mutations have been identified in both types 
of BPES.42,43
Sympathetic nervous system
Ptosis can also be seen in association with dysfunction of the 
sympathetic nervous system, as in Horner syndrome, or with 
other forms of strabismus, including congenital esotropia 
or exotropia.
Horner syndrome
Horner syndrome, also known as Horner–Bernard syn-
drome or oculosympathetic palsy, is a combination of signs 
and symptoms caused by the disruption in the sympathetic 
nervous system of a nerve pathway from the brain to the 
face and eye on one side of the body. Horner syndrome may 
develop from lesions at any point along the sympathetic 
pathway. Central lesions are those between the hypothalamus 
and the fibers that exit from the spinal cord [C8 to T2], while 
Clinical Ophthalmology 2017:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
457
Clinical presentation and management of congenital ptosis
peripheral lesions are mainly located at the superior cervical 
ganglion or in the cervical sympathetic chain. The classic triad 
of ipsilateral miosis, anhidrosis, and ptosis due to dysfunction 
of the sympathetic innervation to the Muller’s muscle is the 
pathognomonic sign of the disorder. Additional signs and 
symptoms in children with Horner syndrome may include 
lighter iris color in the affected eye because of an incomplete 
development of the iris melanocyte due to a deficient sym-
pathetic innervation and a reduction of redness (flushing) on 
the affected side of the face that would normally appear from 
heat, physical exertion, or emotional reactions.44,45
Timing
Appropriate and timely treatment is the result of an accurate 
diagnosis. Correct management of congenital ptosis starts 
with determining the etiology of the ptosis, whether it is a 
genetic condition or if there are systemic syndromes associ-
ated and considering how the vision is affected by the eyelid 
position. These ultimately determine if and when surgical 
management should be undertaken. Congenital mild ptosis 
without serious refractive errors, strabismus, amblyopia, or 
abnormal torticollis should only be considered for cosmetic 
reasons focusing on the psychological impact of the ptosis 
on the child. Patients should be closely monitored for an 
increasing astigmatism due to the compressive force applied 
by the droopy eyelid on the eye or deprivational amblyopia 
that represents the ultimate clinical complication of the 
disorder.4,46,47 Before approaching a surgical intervention, 
avenues of targeted medical treatments are available that 
match the underlying cause of congenital ptosis. A new pro-
spective is represented by the use of gene therapy to provide 
a healthy copy of the mutated genes. However, when the 
upper eyelid interferes with the visual axis (Figure 1) caus-
ing a reduction of the visual field or induces amblyogenic 
astigmatism or abnormal head position, surgical intervention 
is mandatory and has to be performed as soon as possible.47–49 
In other cases, surgery may be postponed; some authors 
recommend waiting until 4 years of age to make the most 
accurate preoperative examination.46
Surgical approach
An accurate preoperative examination includes evaluation 
of the degree of ptosis (measured as the marginal reflex 
distance under the primary gaze), the levator function 
(eyelid excursion from maximal downgaze to maximal 
upgaze with the frontalis muscle immobilized), the position 
and extent of the skin crease and the coexistence of Bell’s 
phenomenon or other associated signs (pupillary changes, 
myasthenic signs, and fundus abnormality). The amount of 
ptosis and the levator function are the two main parameters 
that should be considered before surgery. Among several 
procedures described, the most common and widely used 
are the frontal sling, levator resection, Fasanella–Servat 
procedure, Muller’s muscle resection, and Whitnall liga-
ment sling.
This review focuses on the plethora of surgical approaches 
available for congenital ptosis repair and the surgical indica-
tion depending on the clinical presentation and the underlying 
cause of ptosis. Furthermore, the surgeon’s comfort level and 
experience are important factors that should be considered. 
Careful preoperative evaluation, planning, and counseling 
are necessary to obtain satisfactory surgical results, leading 
to happy parents and patients. Complications and indications 
are summarized in Table 1.50
Procedures
There are several options available with regard to proce-
dures. The autogenous fascia lata is still considered the 
best long-term result material, especially because of a low 
risk of infection or breakage that may occur with foreign 
materials. However, its use in very young patients is limited 
by age and size as for the need of harvesting and additional 
surgery because of reabsorption. The fascia lata is a versa-
tile source of autograft material that is useful in a variety of 
Figure 1 Upper eyelid interferes with the visual axis causing stimulus deprivation or induces amblyogenic astigmatism.
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surgical techniques because of its great dimension, and the 
relatively low morbidity and complications for the donor 
site.51 In facial nerve reanimation surgery, the fascia lata is 
used for static, ancillary procedures such as the labial com-
missure or lower lid suspension.52 Several techniques have 
been described for its harvest, many of which may require 
endoscopes, strippers, or fasciotomes. In case of upper lid 
suspension, only a little amount of fascia lata is needed and 
the harvesting technique is quite easy to perform. The leg 
is medially rotated to expose and easily access the lateral 
surface of the thigh. Under general anesthesia, a skin inci-
sion is made 3–4 cm under an ideal line between the lateral 
condyle of the tibia and the anterior superior iliac crest spine, 
6–8 cm from the knee, and extends upwards 4–5 cm. After 
the skin incision, the underlying fat tissue is dissected to 
reach the fascia. Once the fascia lata is exposed, the graft 
is tailored with a number 15 blade and released from its 
muscular connections by using the Metzenbaum scissors. 
A piece of fascia 5–8 cm long is collected from this site. 
Few absorbable stitches are placed between the two cutting 
edges before donor site closure in order to avoid muscular 
postoperative herniation. Banked fascia lata is an alternative 
option that solves the problem of harvesting and looking for 
new operative sites but may elicit an immune reaction or 
recurrent inflammation. Nonautogenous/synthetic materials 
are preferred to autogenous in very young patients who are 
anatomically too small for fascia lata to be harvested. The 
nonautogenous suspensory materials are elastic and allow 
easier replacement or adjustment when necessary but may be 
subjected to immune reaction or rejection. Among the non-
autogenous materials, the most commonly used are silicone, 
nylon, polyester, gut chromic, polypropylene, collagen, silk, 
and polytetrafluoroethylene. Balacco et al53 described the use 
of Mersilene mesh slings developed in order to overcome 
the problems of failure, slippage, or extrusion within the 
surgical procedure.
Frontalis sling: Crawford technique 
and Fox pentagon
The frontalis sling is the most common surgical technique 
for congenital severe ptosis with high risk of amblyopia 
with ,4 mm of levator function. The frontalis muscle 
elevates the eyebrow and partially the eyelid. This technique 
consists of forming a direct connection between the tarsus 
and the frontalis muscle by creating a double triangle suspen-
sion from the eyelid to the superior eyebrow area. Several 
variations to the original frontalis sling technique have been 
proposed. We may classify the surgical approaches to the 
frontalis sling by considering the connection surface/area 
and the type of material employed into two major groups: 
Crawford frontalis sling technique (using prevalently 
autogenous fascia lata) and Fox pentagon technique (using 
nonautogenous materials)54 (Figure 2).
Crawford technique
Before approaching the surgical procedure on the eyelid area, 
four strips of autogenous fascia lata 10–12 cm long have 
to be collected from the patient’s leg, along a line between 
the caput fibulae and the anterior superior spina iliaca, or 
received from a tissue bank. The skin crease is individuated 
by a lateral, medial, and central skin mark approximately 
3 mm from the lash line. Two more 3 mm skin marks are 
made vertically above on the eyebrow, one slightly laterally 
and the other slightly medially from the eyelid marks cre-
ated before, while a third forehead mark, 5 mm above and 
between the two eyebrow marks, draws an ideal isosceles 
triangle. A Wright fascial needle is used to loop the strips 
through the lid. At this point of the surgery the surgeon has 
Table 1 Choice of surgical technique according to the grade of ptosis and levator function
Technique Indication Levator 
function
Complications
Fasanella–Servat Mild congenital ptosis .10 mm Dermatochalasis, undercorrection, 
overcorrection, bleeding, wound 
dehiscence, corneal abrasion, skin crease 
level defect
Aponeurosis surgery Mild ptosis .10 mm Asymmetric skin crease
Levator resection Mild ptosis .5 mm Corneal exposure, entropion, contour 
abnormality, conjunctival prolapse
Frontalis sling Amblyopia prevention
Severe ptosis
,2 mm Corneal exposure, infection, granulomas
whitnall ligament sling Mild–severe ptosis .3 mm High risk of reintervention
Muller resection Mild ptosis .10 mm Corneal abrasion, undercorrection
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to be careful not to catch/incarcerate the periostium, as it will 
not allow the frontalis muscle to lift the lids. Finally, both 
ends of the strips are tied together while a 6-0 absorbable 
suture reinforces the knot.
Fox pentagon
This surgical procedure is an alternative technique to Craw-
ford’s original frontalis sling. The main difference between 
the two is the use of one single strip made of nonautogenous 
material to connect the lid to the forehead muscles. The sur-
gical technique consists of only two incisions on the eyelids 
instead of the three expected in the Crawford technique, con-
nected to the three higher incisions, two on the eyebrow and 
one on the central forehead as for the Crawford frontalis sling 
(Figure 2A). Pulling the strip through the incisions will draw 
a pentagon rather than two separate triangles (Figure 2B–D). 
Complications such as failure of the surgical procedure, 
extrusion, or slippage can be avoided by the use of a nonab-
sorbable, synthetic material such as Mersilene.53
There is some controversy about whether to perform 
bilateral suspension in patients with unilateral ptosis. A recent 
paper by Nemet55 demonstrates that Hering’s law, which 
refers to the compensatory retraction of the contralateral 
upper eyelid in case of unilateral ptosis, does not manifest 
in congenital ptosis. A bilateral procedure may, however, 
improve the symmetry between the eyes.
The frontalis sling is a simple, well-known procedure 
(Figure 3), that can be repeated or revised if needed. How-
ever, the use of autogenous materials limits the time and 
chances available to be removed as they easily incorporate 
Figure 2 Fox pentagon technique.
Notes: (A) Skin mark. (B) wright’s fascial needle. (C) Control the eyelid shape. (D) Nylon tied together.
Figure 3 (A) Preoperative and (B) postoperative result of frontalis sling procedure in a case of severe ptosis.
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into the tissue. Nonautogenous materials can otherwise be 
removed at any time and do not exacerbate the inflammatory 
granulomatous reactions, although they might be exposed to 
rejection. Other limits to the use of the frontalis sling surgical 
technique are the moderate immobilization of the lids and the 
increase in postsurgical lagophthalmos during sleep or in the 
extreme downgaze because of the concomitant orbicularis 
muscle detention.
Levator’s resection and aponeurosis 
surgery
This technique is indicated in the correction of ptosis in 
patients with .5 mm of levator function. It enhances the 
elevator function by shortening the elevator complex (muscle 
and aponeurosis) (Figure 4).
In order to obtain an acceptable level of eyelid suspen-
sion, Collins50 suggests to work on the following amount of 
resection:
Levator function 8–10 mm: 14–18 mm resection
Levator function 6–7 mm: 18–22 mm resection
Levator function 4–5 mm: 22–26 mm resection.
There are two possible approaches described. The anterior 
approach consists of exposure of the levator aponeurosis 
using a superior eyelid crease incision and the advancement 
of the levator aponeurosis by folding or excising the muscle. 
The aponeurosis is reattached to the anterior surface of the 
tarsus with nonabsorbable sutures. The transconjunctival 
approach or the small skin incision (8–13 mm) represents 
an alternative to the anterior procedure, leading to a reduced 
distortion of the tissue and a better cosmetic result. The main 
disadvantage of the small incision approach is otherwise the 
limited view of the surgical field. The benefits obtained by 
this type of surgery are the preservation of the anatomical 
planes and the elevating structures of the eyelids, including 
Muller’s muscle and Whitnall’s ligament. Furthermore, 
it allows the surgeon to customize the amount of eyelid 
elevation intraoperatively. Although the levator resection 
outcomes are not completely predictable, a 10-year retro-
spective study conducted by Abrishami et al56 on a group 
of patients where congenital ptosis accounted for an 88.2% 
reports an overall success rate of 78.7%, which increased 
after the second and/or third procedures. This is in line with a 
previous study conducted by Cates and Tyers57 who reported 
an overall 76% success rate, falling to 74% at 6 months post-
operatively. Scuderi et al report the success of this technique 
associated with Muller’s muscle technique.58
Muller’s muscle resection
Muller’s muscle resection was first described by Putternam 
in 1985.59 Muller’s muscle is responsible for eyelid elevation 
up to 2–3 mm. The indication for this type of surgery is the 
resolution of ptosis after one drop of phenylephrine associ-
ated with a good function of levator muscle. A conjunctival 
approach was originally proposed to pursue resection of 
the Muller’s muscle and the conjunctiva, without involv-
ing the tarsus. An open sky approach was later introduced 
to save the healthy conjunctiva and avoid an incorrect and 
limited muscle resection.60 Baldwin et al obtained successful 
results from the Muller muscle-conjunctiva resection in phe-
nylephrine test-negative patients with ptosis.61 The potential 
complication is the corneal abrasion because of the exposed 
sutures, risk of upper fornix alteration, damage to accessory 
tear glands and upper lid entropion.62
Whitnall ligament sling
The Whitnall ligament sling procedure is indicated in cases 
of mild-to-severe ptosis with a levator function .3 mm.63,64 
The role and anatomical position of the Whitnall’s ligament 
were first described by Anderson et al.65 It is an orbital fascial 
condensation that crosses the anterosuperior orbit between 
the trochlea and the lacrimal gland fascia, and lies near the 
junction of the muscular and aponeurotic levator. Because 
of its hidden position, it might be intraoperatively confused 
with other structures of the levator complex or mistaken as 
if frequently happens with the transverse ligament. If these 
mistakes happen, the elevation will be insufficient and the 
surgical outcome will be poor. The Whitnall sling procedure 
allows improving the effort of the levator muscle by adding a 
sustainment structure to the eyelid. The levator aponeurosis is 
cut up to the point of the maximal levator resection, and both 
the levator muscle and the overlying Whitnall’s ligament are 
sutured to the superior portion of the tarsal plate.64Figure 4 Aponeurosis of the levator muscle.
Clinical Ophthalmology 2017:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
461
Clinical presentation and management of congenital ptosis
Fasanella–Servat
The Fasanella–Servat procedure was first described in 1961.66 
The technique is generally used for those patients who pres-
ent with a good levator function and ptosis ,3 mm. The 
Fasanella–Servat procedure might also be used in congenital 
ptosis with poor levator function because of the surgeon’s 
choice not to remove the healthy tarsus for its functional role 
in eyelid stability. Fasanella–Servat reduces ptosis by remov-
ing conjunctival tissue, Muller muscle, and part of the tarsus 
using a posterior internal eyelid approach. Many studies have 
been carried out and dozens of adjustments to the original 
technique have been proposed by oculoplastic surgeons to 
achieve betters results.67 In the original Fasanella–Servat 
procedure, the eyelid is gently everted, and the upper border 
of the tarsus is clamped to the inferior side of the Muller’s 
muscle and conjunctiva. After clamping, the same needle 
is used to create a running suture with an absorbable suture 
through the lid margin. The sutures stay in place for a few 
days while the artery forceps are removed. Both arms of the 
suture are then pulled through the conjunctival wound and 
tied. The use of softer suture has consistently reduced one of 
the main complications represented by the corneal irritation 
due to scratching. Other common complications include 
faulty placement of the clamps, postoperative keratitis, suture 
granuloma, and postoperative hemorrhages. A damage to the 
lacrimal glands may worsen the superficial keratopathy. As 
a result of the loss of conjunctival tissue from the superior 
fornix, an entropion may form. Many authors have studied the 
success rate of the Fasanella–Servat procedure in congenital 
ptosis. Pang et al performed 169 cases of ptosis repair using 
Fasanella–Servat. In this study, only 18 cases were classi-
fied as congenital ptosis. The success rate was 89.5%, but 
congenital cases had the lowest success rate of all studied 
subgroups (76.4%). In a larger study of 155 congenital 
ptosis, Berry-Brincat et al performed 15 Fasanella–Servat 
procedures.The overall success rate was 71%, with a 20% 
reintervention rate.5
Discussion
The most common and resolutive approach to the treatment 
of congenital ptosis and its phenotypical presentation is 
surgical intervention. The recommendations can be either 
functional or aesthetic. Accurate preoperative evaluation is 
undoubtedly the most important thing to consider in order to 
plan a timely, valuable surgery and to choose the best surgical 
technique that adapts to the clinical presentation and the 
underlying cause of ptosis. Above all, the levator’s function 
and the degree of ptosis in primary position represent the 
parameters that should guide this choice. The optimal time 
for intervention is related to the visual impairment and the 
psychological impact on the young patient. When the upper 
eyelid interferes with the visual axis, leading to deprivation or 
developing a compressive astigmatism, the risk of amblyopia 
is high. The surgical correction of blepharoptosis induces 
anterior corneal surface modification, restoring corneal sym-
metry and regular corneal astigmatism.68 However, recent 
papers demonstrate that both blepharoplasty and levator 
resection may induce significant changes of corneal curvature 
(eg, central corneal power and corneal astigmatism) by repo-
sitioning of the upper eyelid.69 Deprivational amblyopia4,46,47 
represents the only emergency that requires immediate surgi-
cal intervention. In this case, the frontalis sling is the most 
commonly used and recommended procedure. A limit to this 
type of technique in very young patients might be the insuf-
ficient length of the leg for harvesting the fascia lata. The 
Fox pentagon technique overcomes this problem by using 
nonautogenous, synthetic materials that can be adapted to 
the growth of the patient. Several studies have shown that 
this material does not integrate with the fabrics and offers the 
possibility of reintervention.
The most common complications described are under- 
or overcorrection and lagophthalmos, leading to superficial 
punctate keratitis or even corneal ulcer, depending on the 
degree of exposure. The surgical outcome is therefore con-
sidered very poor as these conditions are associated with 
high ocular discomfort or pain. Other surgical techniques that 
require a conjunctival approach such as the Fasanella–Servat 
and the Muller’s muscle resection, may present with the same 
pattern of superficial complications like corneal abrasions 
due to the exposure of conjunctival sutures.
Complications that belong to the material used for the 
frontal sling are widely described by Simon.70 Although 
autogenous materials, such as fascia lata, allow an optimal 
execution of the surgical intervention, they require a proper 
length of the leg to be harvested. The very young age and 
the limited physical development of patients (usually under 
3 years old) who undergo this procedure is a limit to the use 
of autogenous materials.71 Another limitation to the use of 
fascia lata is the high incidence of severe infections due to 
its exposure. Further reinterventions are also not allowed as 
the autogenous materials rapidly integrate with the tissues. 
Alternatively, nonautogenous materials like Mersilene pres-
ent a very low risk of reintervention (~12.5%) but few soft 
tissue complications as reported by Mehta et al.72 The nylon 
monofilament is extremely easy to use but is affected by a 
high recurrence rate.71
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Conclusion
In literature, several different options to correct congenital 
ptosis are described. The treatment of eyelid ptosis associated 
with a rare disease does not differ from the management of 
congenital ptosis. Frequently, more than one surgical inter-
vention is required to pursue a satisfactory surgical outcome. 
The choice of the surgical technique adopted depends on the 
experience of the surgeon but mainly on preoperative con-
siderations. The grade of ptosis, the levator eyelid function, 
and the risk of amblyopia are the parameters that will guide 
the timing and the choice of the surgical technique.
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